Disease X Act of 2023

Bill: 118-hr-3832
Sponsor: full_name: Rep. Trahan, Lori [D-MA-3]
Introduced: 2023-06-05
Policy area: Health
Subjects: Advanced technology and technological innovations

Infectious and parasitic diseases

Medical research

Research administration and funding

Research and development
Latest action: action_date: 2023-06-09
text: Referred to the Subcommittee on Health.

Summaries:
action_date: 2023-06-05
action_desc: Introduced in House
text: <p><b>Disease X Act of 2023</b></p> <p>This bill expands the priorities of the Biomedical Advanced Research and Development Authority (BARDA) to specifically include viral threats that have the potential to cause a pandemic.</p> <p>In particular, the bill expands the scope of innovation grants and contracts that may be awarded by BARDA to specifically include those that support research and development of certain manufacturing technology for medical countermeasures against viruses, including respiratory viruses, with pandemic potential. It also expands BARDA's authorized strategic initiatives to include advanced research, development, and procurement of countermeasures and products to address viruses with pandemic potential. </p>

tv_txt: I 118th CONGRESS 1st Session H. R. 3832 IN THE HOUSE OF REPRESENTATIVES June 5, 2023 Mrs. Trahan (for herself, Mr. Burgess , Mr. Crenshaw , and Ms. Lee of Nevada ) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To establish a program at BARDA for developing medical countermeasures for viral threats with pandemic potential.

1. Short title This Act may be cited as the Disease X Act of 2023 . 2. Medical countermeasures for viral threats with pandemic potential Section 319L(c)(4) of the Public Health Service Act (42 U.S.C. 247d–7e(c)(4)) is amended— (1) in subparagraph (D)— (A) in clause (ii), by striking ; and and inserting a semicolon; (B) by redesignating clause (iii) as clause (v); and (C) by inserting after clause (ii) the following: (iii) the identification and development of platform manufacturing technologies needed for advanced development and manufacturing of medical countermeasures for viral families which have significant potential to cause a pandemic; (iv) advanced research and development of flexible medical countermeasures against priority respiratory virus families and other respiratory viral pathogens with a significant potential to cause a pandemic, with both pathogen-specific and pathogen-agnostic approaches; and ; and (2) in subparagraph (F)— (A) in clause (ii), by striking ; and at the end and inserting a semicolon; (B) in clause (iii), by striking the period and inserting ; and ; and (C) by adding at the end the following: (iv) priority virus families and other viral pathogens with a significant potential to cause a pandemic. .